Inventor · disambiguated record
Arthur Lee
Also filed as: LEE ARTHUR · LEE ARTHUR E
25 granted patents·22 pending applications·122 citations·filing 2002–2025
95Inventor score
Files withBOLT BIOTHERAPEUTICS INC18PFIZER9BRIGHAM & WOMENS HOSPITAL INC6QUANTUMSINE ACQUISITIONS INC4UNIV LELAND STANFORD JUNIOR4
Top patents by PatentIndex Score
47 records- 0197US11702424B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2020·Granted Jul 18, 2023·4 cites·8 claims
- 0295US9879022B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2016·Granted Jan 30, 2018·19 cites·22 claims
- 0395US9458168B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2015·Granted Oct 4, 2016·17 cites·44 claims
- 0493US9407203B2Combined amplitude-time and phase modulationQUANTUMSINE ACQUISITIONS INC·Filed 2014·Granted Aug 2, 2016·18 cites·12 claims
- 0592US11110178B2Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Sep 7, 2021·3 cites·30 claims
- 0692US9774348B2Combined amplitude-time and phase modulationQUANTUMSINE ACQUISITIONS INC·Filed 2016·Granted Sep 26, 2017·13 cites·4 claims
- 0791US11654147B2ALK2 inhibitors and methods for inhibiting BMP signalingBRIGHAM & WOMENS HOSPITAL INC·Filed 2021·Granted May 23, 2023·3 cites·13 claims
- 0891US10793579B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2019·Granted Oct 6, 2020·3 cites·8 claims
- 0991US10675358B2Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Jun 9, 2020·5 cites·30 claims
- 1087US9682983B2BMP inhibitors and methods of use thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Granted Jun 20, 2017·10 cites·19 claims
- 1186US10329302B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2018·Granted Jun 25, 2019·3 cites·2 claims
- 1285US12202836B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2023·Granted Jan 21, 2025·0 cites·14 claims
- 1385US11142695B2Anti-oxidant compounds and compositionsLEE DUK HI·Filed 2019·Granted Oct 12, 2021·2 cites·7 claims
- 1485US10174000B2Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulatorsPFIZER·Filed 2016·Granted Jan 8, 2019·5 cites·10 claims
- 1582US11026947B2ALK2 inhibitors and methods for inhibiting BMP signalingBRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Granted Jun 8, 2021·4 cites·23 claims
- 1681US10382246B2Combined amplitude-time and phase modulationQUANTUMSINE ACQUISITIONS INC·Filed 2017·Granted Aug 13, 2019·3 cites·20 claims
- 1781US10017516B2BMP inhibitors and methods of use thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Jul 10, 2018·3 cites·5 claims
- 1879US10316018B2Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulatorsPFIZER·Filed 2018·Granted Jun 11, 2019·2 cites·4 claims
- 1977US10513521B2Compositions and methods for inhibiting BMPBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Granted Dec 24, 2019·3 cites·19 claims
- 2075US2023111340A1Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 2174US11547761B1Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Jan 10, 2023·0 cites·91 claims
- 2268US11400164B2Immunoconjugates targeting HER2BOLT BIOTHERAPEUTICS INC·Filed 2021·Granted Aug 2, 2022·0 cites·44 claims
- 2366US2022347311A1Immunoconjugates Targeting HER2BOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2462US11242444B2Triazine compounds, compositions, and methodsLEE DUK HI·Filed 2019·Granted Feb 8, 2022·0 cites·30 claims
- 2562US2020108151A1Antibody adjuvant conjugatesBOLT BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2661US2022195066A1Anti-cea immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2761US2025263392A1Aminobenzazepine compounds, immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2859US7407978B2Heterocyclic analogs of diphenylethylene compoundsTHERACOS INC·Filed 2002·Granted Aug 5, 2008·1 cites·6 claims
- 2957US7718682B2Heterocyclic analogs of diphenylethylene compoundsTHERACOS INC·Filed 2008·Granted May 18, 2010·0 cites·32 claims
- 3057US2019015516A1Antibody adjuvant conjugatesBOLT BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3155US11140018B2Method and apparatus for intra-symbol multi-dimensional modulationQUANTUMSINE ACQUISITIONS INC·Filed 2019·Granted Oct 5, 2021·1 cites·17 claims
- 3253US2024033370A1Anti-pd-l1 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3353US2020390899A1Aminobenzazepine compounds, immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3453US2023278967A1Novel anti-oxidant compounds and compositionsLEE DUK HI·Filed 2022·Application pending·0 cites
- 3553US2006235062A1Novel heterocyclic analogs of diphenylethylene compoundsTHERACOS INC·Filed 2003·Application pending·0 cites
- 3653US2024238430A1Anti-cea immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3752US2024042050A1Anti-her2 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3852US2024091370A1Anti-her2 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3946US2022152215A1Immunoconjugates Targeting CEABOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4046US2022226492A1Immunoconjugates Targeting HER2BOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4146US2022347312A1Immunoconjugate Synthesis MethodBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4246US2022226491A1Immunoconjugates Targeting PD-L1BOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4346US2022143012A1Macromolecule-Supported TLR AgonistsBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4446US2021187115A1Immunoconjugates Targeting EGFRBOLT BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4539US2021284750A1Immunoconjugate Synthesis MethodBOLT BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4638US2018230127A1Bicyclic-Fused Heteroaryl Or Aryl CompoundsPFIZER·Filed 2016·Application pending·0 cites
- 4734US2017305883A1Compositions and Methods for Inhibiting BMPBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Arthur Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →